Trading Signals: ADAP Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Fri. May. 28, 2021)(Adaptimmune Therapeutics plc)
| ADAP latest price $5.1500 (4.25%) ($5.1500 - $5.1500) on Thu. Apr. 8, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.46% (three month average) | RSI | 51 | Latest Price | $5.1500(4.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ADAP declines -0.6% a day on average for past five trading days. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ADAP advance at 0% a week (0% probability) XLC(35%) XLU(36%) ACES(30%) XBI(30%) VYM(29%) | Factors Impacting ADAP price | ADAP will decline at least -2.23% in a week (0% probabilities). IWD(18%) ICLN(13%) JETS(-3%) IYT(9%) IWO(14%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.23% (StdDev 4.46%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $5.29 | 5 Day Moving Average | $5.3(-2.83%) | 10 Day Moving Average | $5.22(-1.34%) | 20 Day Moving Average | $5.29(-2.65%) | To recent high | -24.7% | To recent low | 2.5% | Market Cap | $796m | | | | Adaptimmune Therapeutics Plc engages in the development of novel cancer immunotherapy products. Its specific peptide enhanced affinity receptor platform enables the engineering of T-cells to target and destroy cancer, including solid tumors. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom. |